Gina Mauro

CURE spoke with Dr. Natalie S. Berger for the latest episode of the "Cancer Horizons" podcast.

Oncology nurse practitioners discuss CD38-based frontline therapy for newly diagnosed multiple myeloma, including Dara-VRd efficacy, adverse event management, and subcutaneous administration strategies.

Maurie Markman, MD, joins The Moonlight Shift to discuss precision medicine's real-world limits, oncology's cost crisis, CAR-T in solid tumors, and the decision support gap costing patients.

In this episode of The Moonlight Shift, Joshua Richter, MD, associate professor of medicine in The Tisch Cancer Institute, Division of Hematology and Medical Oncology, and director of Multiple Myeloma at the Blavatnik Family- Chelsea Medical Center at Mount Sinai, joins host Gina Mauro for a conversation about a disease he says he can no longer describe the way he once did — and why that change is one of the most remarkable shifts in modern oncology.

Joshua Richter, MD, joins The Moonlight Shift to discuss "cure" in relation to myeloma treatment, the linvoseltamab pipeline journey, and myths surrounding myeloma care.

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

Jonathan Lee, MD, MSc, and Chinmay Jani, MD, have a candid conversation about what medical training actually feels like.

In this episode of the Moonlight Shift, Jonathan Lee, MD, and Chinmay Jani, MD, dive into the ins and outs of oncology fellowship and training.

Dr. Paul Oberstein discusses RASolute 302, a pancreatic cancer trial, and what a potential KRAS inhibitor breakthrough could mean for patients.